rezolutebio.com (RZLT): Dana dhuwit perusahaan

Logo perusahaan publik Rezolute Corp (RZLT)

Rezolute, Inc. (RZLT) utilizes a virtual business model, fully outsourcing production and testing to third-party contractors. The cash balance reflects liquidity trends, with the parameter stabilizing at 0.09. The company focuses on hypoglycemia therapy, where the success of the RZ358 drug depends on FDA decisions. However, the lack of profitability and regular secondary offerings create significant risks of shareholder equity dilution.

RZLT - Cadangan dhuwit perusahaan Rezolute Bio ing rentang 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Rezolute Inc (RZLT)

- nilai saham lan prakiraan konsensus rega:
Analisis umum perusahaan:Rezolute Bio RZLT
Produk mawa merek Rezolute

To minimize default risks, investors must assess liquidity via the cash balance on the balance sheet, which measures the available cash reserves to cover operating expenses. By analyzing cash capital dynamics, one can determine the burn rate of Rezolute, Inc. (RZLT), which is critical for funding the development of drugs for rare metabolic diseases until the generation of the first commercial revenue.

Analisis perusahaan pesaing

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)